Specular Microscopy in Patients With Proliferative Diabetic Retinopathy
Changes of Corneal Endothelial Cells in Patients With PDR Using Specular Microscopy
1 other identifier
observational
60
0 countries
N/A
Brief Summary
.1. corneal endothelial profile in patients with proliferative diabetic retinopathy compared to a healthy age-matched control group. 2\. The effect of the age, and duration of Diabetes on the corneal endothelium .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2022
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMay 3, 2023
April 1, 2023
1.6 years
September 9, 2022
April 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
To predict the effect of Diabetes on the cornea of diabetic patients
To evaluate corneal endothelial changes in patients with Proliferative diabetic retinopathy compared to normal group of the same age and gender using Specular microscopy
Baseline
Interventions
Non-contact Specular microscopy is a non-invasive method that allows for in vivo study of corneal endothelium.
Eligibility Criteria
Image capture will be done by the same individual for all subjects. The following data will be collected and analyzed: corneal endothelial cell count, coefficient of variation, percentage of hexagonal cells and central corneal thickness.
You may qualify if:
- patients with Type I or II Diabetes Mellitus
- Diagnosed with proliferative diabetic retinopathy . .Intraocular pressure less than 21mmHg.
- Healthy controls:
- Healthy individuals aged 40 to 70 years of both sexes. .Intraocular pressure less than 21 mmHg.
You may not qualify if:
- Diabetic group:
- Associated ocular diseases that may affect the corneal endothelium such as uveitis, glaucoma, and dystrophy, prolonged CLs use.
- Previous ocular trauma or surgery.
- Healthy control:
- Any systemic diseases that may affect corneal endothelium function.
- Associated ocular diseases that may affect the corneal endothelium such as uveitis, glaucoma, and dystrophy, prolonged CLs use.
- Previous ocular trauma , surgery ,laser or intraocular injection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Mortazavi SA, Akhlaghi M, Dehghani A, Pourazizi M, Malekahmadi M, Fazel M, Tavakoli M, Noorshargh P. Diabetic retinopathy and corneal endothelial parameters: an analytical cross-sectional study. BMC Ophthalmol. 2022 Nov 9;22(1):427. doi: 10.1186/s12886-022-02667-6.
PMID: 36348282BACKGROUNDJha A, Verma A, Alagorie AR. Association of severity of diabetic retinopathy with corneal endothelial and thickness changes in patients with diabetes mellitus. Eye (Lond). 2022 Jun;36(6):1202-1208. doi: 10.1038/s41433-021-01606-x. Epub 2021 Jun 11.
PMID: 34117392BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmologist
Study Record Dates
First Submitted
September 9, 2022
First Posted
May 3, 2023
Study Start
June 1, 2023
Primary Completion
January 1, 2025
Study Completion
June 1, 2025
Last Updated
May 3, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share